20398 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
HETEROCYCLIC INHIBITORS OF PDE4
#302Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#303Protein kinase C as a target for the treatment of respiratory syncytial virus
#304Medicaments
#305Formulation for oral administration with beneficial effects on the cardiovascular system
#306Compositions and methods for treating amyloidosis
#307Mast cell stabilizers in the treatment of obesity
#3084-ACYLAMINOPYRIDINE DERIVATIVE MEDIATED NEUROGENESIS
#309Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#310Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent
#311Method of Treating Tumors with Azaxanthones
#312Nasal irrigation solutions and methods of using same
#313PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
#314N-substituted indenoisoquinolines and syntheses thereof
#315ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
#316Protein kinase C as a target for the treatment of respiratory syncytial virus
#317Methods and compounds for inhibiting amyloid deposits
#318METHOD FOR PREVENTING PLANT DISEASES
#319Memory influencing protein
#320Genipin derivatives and uses thereof
#321Method of Administration of Dopamine Receptor Agonists
#322Compounds and methods for the treatment of asthma
#323THERAPEUTIC AGENT FOR SCHIZOPHRENIA
#324Compositions and methods of treatment using modulators of motoneuron diseases
#325Methods of using small molecule compounds for neuroprotection
#326METHOD FOR THE TREATMENT AND DIAGNOSIS OF CERTAIN PSYCHIATRIC DISORDERS RELATED TO THE MENSTRUAL CYCLE
#327Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
#328Thienopyridine and furopyridine kinase inhibitors
#329Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
#330Method of treating tumors with azaxanthones
#331Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
#332Method and composition for controlling oral pathogens
#333Solid forms of a chemokine receptor antagonist and methods of use thereof
#334Methods of prevention of infection with HIV/AIDS, venereal disease and influenza
#335Combination therapy for treating obesity or maintaining weight loss
#336A composition for preventing plant diseases resulted from infection of plant pathogens and a method for preparing the same
#337Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
#338In situ controlled release drug delivery system
#339Opiopathies
#340Therapeutic agent for schizophrenia
#341Antipsychotic molecular-targeting epithelial growth factor receptor
#342Combination therapies of cicletanine and carvedilol
#343Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
#344Combination therapies of cicletanine and magnesium
#345Genipin derivatives and uses thereof
#346Androgen receptor agonists
#347Inhibitor of the shh signalling patway and a testosterone supressing agent for the treatment of cancer
#348Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
#349Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
#350Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#351Noscapine derivatives as adjuvant compositions and methods of use thereof
#352Methods for treating inflammatory and autoimmune diseases
#353Methods of treating a disorder
#354Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
#355Method of treatment of dopamine-related dysfunction
#356Anti-constipation composition
#357Aerosol formulations containing P134a and particulate medicament
#358Ester or amide derivatives
#359Medicaments
#360Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
#361Medicaments comprising inhibitors of the cell volume-regulated human kinase h-sgk
#362Thienopyridine and furopyridine kinase inhibitors
#363Methods for improved treatment of cancer with irinotecan based on mrp1